Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNCE
3451
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.35M | ﹤0.01% |
320,622
-217,899
| -40% | -$922K |
|
3452
Acme United Corp
ACU
$217M
| $1.34M | ﹤0.01% |
30,158
+6,792
| +29% | +$292K |
|
3453
Shinhan Financial Group
SHG
$32.8B
| $1.34M | ﹤0.01% |
37,432
-2,972
| -7% | -$107K |
|
|
ACR
3454
ACRES Commercial Realty
ACR
$124M
| $1.34M | ﹤0.01% |
83,429
+4,836
| +6% | +$77.1K |
|
|
AMRN
3455
Amarin Corp
AMRN
$299M
| $1.34M | ﹤0.01% |
15,286
+180
| +1% | +$17.7K |
|
|
DMS
3456
DELISTED
Digital Media Solutions, Inc.
DMS
| $1.34M | ﹤0.01% |
9,226
+3,001
| +48% | +$494K |
|
3457
Pixelworks
PXLW
$38.2M
| $1.34M | ﹤0.01% |
32,666
-27,507
| -46% | -$1.08M |
|
|
PWOD
3458
DELISTED
Penns Woods Bancorp
PWOD
| $1.33M | ﹤0.01% |
55,954
-42,405
| -43% | -$1.04M |
|
3459
Medallion Financial
MFIN
$229M
| $1.33M | ﹤0.01% |
150,108
+3,699
| +3% | +$31.9K |
|
|
LCI
3460
DELISTED
Lannett Company, Inc.
LCI
| $1.32M | ﹤0.01% |
70,769
-60,620
| -46% | -$1.16M |
|
3461
C&F Financial
CFFI
$268M
| $1.32M | ﹤0.01% |
25,873
-19,797
| -43% | -$929K |
|
3462
Elicio Therapeutics
ELTX
$73.5M
| $1.32M | ﹤0.01% |
10,129
+598
| +6% | +$86.3K |
|
3463
Newegg Commerce
NEGG
$279M
| $1.32M | ﹤0.01% |
+3,400
| New | +$682K |
|
|
AAIC
3464
DELISTED
Arlington Asset Investment Corp.
AAIC
| $1.31M | ﹤0.01% |
323,450
-235,763
| -42% | -$956K |
|
|
EVFM
3465
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $1.31M | ﹤0.01% |
77,386
-10,737
| -12% | -$204K |
|
|
MBCN
3466
DELISTED
Middlefield Banc Corp
MBCN
| $1.31M | ﹤0.01% |
55,502
-40,071
| -42% | -$914K |
|
3467
Galectin Therapeutics
GALT
$196M
| $1.31M | ﹤0.01% |
409,013
-236,854
| -37% | -$843K |
|
|
GMBL
3468
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
| $1.31M | ﹤0.01% |
3
+1
| +50% | +$471K |
|
3469
Esquire Financial Holdings
ESQ
$1.12B
| $1.3M | ﹤0.01% |
55,060
-46,772
| -46% | -$1.11M |
|
|
RYM
3470
RYTHM Inc
RYM
$39.5M
| $1.3M | ﹤0.01% |
37
-6
| -14% | -$188K |
|
3471
ICICI Bank
IBN
$108B
| $1.3M | ﹤0.01% |
76,150
+9,192
| +14% | +$153K |
|
|
SRGA
3472
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $1.3M | ﹤0.01% |
31,242
-20,390
| -39% | -$1.04M |
|
3473
INmune Bio
INMB
$46.5M
| $1.3M | ﹤0.01% |
73,794
+12,957
| +21% | +$175K |
|
3474
Amplify Energy
AMPY
$161M
| $1.29M | ﹤0.01% |
319,861
+33,085
| +12% | +$110K |
|
3475
Innoviz Technologies
INVZ
$95M
| $1.29M | ﹤0.01% |
+122,242
| New | +$1.27M |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.